Nominations for New Members to Join the HHS Panel on the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children
The HHS Panel on the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children (or the Panel) is accepting nominations for new scientific/clinical members with expertise in pediatric HIV infection and infectious diseases to join the Panel.
Panel members critically evaluate new information and revise the guidelines with assistance from the Panel’s coordinator and editorial support staff, and under the guidance of the Leadership and Executive Secretary. The candidates shall be recognized experts in pediatric HIV and opportunistic infectious diseases. Special interests in the following areas are desirable but not required:
- Invasive bacterial infections
- Parasitology
- Travel medicine
- Herpes Viruses
- Candida infections
- Immunizations
The selected candidates shall serve a four-year term beginning April 2022, with potential for reappointment. Because these guidelines are focused on management of HIV-exposed and HIV-infected children within the United States, candidates should be from the United States.
The Panel is a Working Group of the Office of AIDS Research Advisory Council (OARAC) of the National Institutes of Health (NIH). The Panel is comprised of approximately 30 members who are clinicians, researchers, academicians, and HHS representatives with expertise in management of opportunistic infections and illnesses in HIV-exposed and HIV-infected children, pre-adolescents, and adolescents.
The Panel meets biannually via teleconferencing to review and critically evaluate emerging scientific data relating to approvals of new drugs, vaccines, medical devices, or diagnostics; new information regarding indications or dosing; new safety or efficacy data; or other information that may affect prevention and treatment of HIV-related opportunistic infections in children and to revise the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children.
Panel members are not financially compensated for their time commitment.
The nomination should include a curriculum vitae or resume, and a letter of nomination or letter of interest with specific reference to how the nominee would contribute to the work of the Panel. Please submit all supporting documents to Adam Malleck, Clinicalinfo Guidelines Coordinator, at adam.malleck@nih.gov. Nominations will be accepted until Monday, February 28, 2022.